The EU Listing Act came into force on 4 December 2024 with the aim of making the capital market in Europe more attractive overall. The Act introduces some significant amendments to the EU Market Abuse Regulation, particularly with regard to issuers’ public disclosure obligations, as well as for managers’ transactions (directors’ dealings) and share buy-back programmes. Our GSK Update outlines the key new rules and highlights the changes with which issuers in particular will have to comply.
04.09.2025
